Sapience Therapeutics, Inc.

  • Home
  • About
    • Overview
    • Team
    • Directors
    • Advisors
  • Our Approach
    • Overview
    • Therapeutic Approach
    • Discovery Platform
  • Pipeline
    • Overview
    • ST101
    • β-Catenin Antagonist
    • cJun Antagonist
    • cMyc Antagonist
    • FoxP3 Antagonist
    • Expanded Access
  • Partnering
  • Careers
  • News & Events
    • Press Releases
    • Events
    • Publications
    • Presentations
    • Email Alerts
  • Contact

Press Releases

News & Events

News & Events

  • Press Releases
  • Events
  • Publications
  • Presentations
  • Email Alerts
Sep 13, 2021 4:05pm EDT

Sapience Therapeutics Announces Poster Presentation on ST101 at the European Society for Medical Oncology (ESMO) Congress 2021

Jul 29, 2021 8:00am EDT

Sapience Therapeutics Commences Dosing in Final Dose-Escalation Cohort of Ongoing Phase 1-2 Study of ST101

Jul 15, 2021 8:00am EDT

Sapience Therapeutics to Participate at SVB Leerink Biopharma Private Company Connect

Jun 09, 2021 8:00am EDT

Sapience Therapeutics to Present at BIO Digital 2021

May 27, 2021 4:30pm EDT

Sapience Therapeutics Enters Into Collaboration with National Cancer Institute (NCI) to Study ST101 Response in Specialized Tumor Models

May 18, 2021 4:05pm EDT

Sapience Therapeutics Awarded SBIR Phase I Grant from National Institute of Allergy and Infectious Diseases

Apr 06, 2021 4:05pm EDT

Sapience Therapeutics Announces Multiple Posters, Including Late-Breaker, at the American Association for Cancer Research (AACR) Annual Meeting 2021

Mar 04, 2021 8:30am EST

Sapience Therapeutics to Present at the Upcoming 2021 Spring Private Company Showcase hosted by Credit Suisse, Solebury Trout, and Cooley

Dec 01, 2020 9:30am EST

Sapience Therapeutics Appoints J. Andrew Sanford to Its Board of Directors

Nov 19, 2020 8:30am EST

Sapience Therapeutics Renews Drug Discovery Pact with the University of Bath

  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next
RSS
© 2022 Sapience Therapeutics, Inc. All Rights Reserved.
linkedin
Privacy Policy Disclaimer Sitemap